BNTX and MRNA Related Headlines
Go Back- Moderna jumps as vaccine shows benefit in head and neck cancer in early study
- Moderna (MRNA) Trades Lower in Sympathy with BioNTech (BNTX)
- BioNTech says EU Patent Office declared Moderna patent invalid
- Stock Market Today: Dow ends higher on tech gains as earnings season to heat up
- S&P 500 jumps as big tech soaks up demand, shrugs off rising Treasury yields
- Apple, Nvidia and Pfizer fall premarket; Lululemon rises
- Moderna (MRNA) declines on concerns about takeup of Covid booster
- COVID-19 vaccine stocks gain as Biden expected to request new vaccine, recommended for all
- COVID-19 vaccine stocks gain pre-open as Biden to request new vaccine, recommended for all
- US CDC says new COVID lineage could cause infections in vaccinated individuals
- Why Moderna (MRNA) could see COVID-19 vaccine share gains this fall
- FDA Advisers Back Updating Covid Shots To Target XBB Subvariant - Bloomberg
- BioNTech SE (BNTX) on Watch Following NYT Report "Pancreatic Cancer Vaccine Shows Promise in Small Trial"
